News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Exclusive Coverage of the American Heart Association (AHA) Scientific Sessions 2023

Understanding Elevated Lipoprotein(a): A Focus on Cardiovascular Risk and Screening Recommendations

ByLibbi Green, PharmD

March 8th 2024

A Real-World Study of Patients With ASCVD Demonstrates Prevalence of High LDL-C, Demographic Disparities, and Underutilization of Lipid-Lowering Therapy

ByErin Garrow, PhD

March 8th 2024

Exploring Patterns in Lp(a) Testing and Lipid-Lowering Therapy Prescription Across 5 Major US Health Systems in Patients With Atherosclerotic Cardiovascular Disease

ByDorothy Cooperson Vieweg

March 8th 2024

Insights Into Lipoprotein(a) Screening Trends: Analysis of a Comprehensive US Health Care Dataset

ByAmanda Meyer, MS

March 8th 2024

Lp(a): Evidence of a Link to Major Adverse Cardiovascular Events

ByJabir Bhuiyan, MS

March 8th 2024

Elevated Lipoprotein(a) Increases Cardiovascular Risk Independently of SMuRFs

ByAmanda Meyer, MS

March 8th 2024

Examining Low Rates of Real-World Lp(a) Testing: Insights From a Decade-Long Cohort Study in a Diverse Health System

ByDorothy Cooperson Vieweg

March 8th 2024

Prospective Atherosclerosis Risk in Communities (ARIC) Study Connects Differences in Lipoprotein(a) With Racial Disparities in Atherosclerotic Cardiovascular Disease

ByErin Garrow, PhD

March 8th 2024

Trending on AJMC

Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects

Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025

Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention

The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs

Inebilizumab Benefit in gMG Holds at 1 Year: Richard J. Nowak, MD, MS